Drugs@FDA document

ALIMTA Other Important Information from FDA · NDA 021677 ORIG-1

Drugs@FDA document · LILLY · Apr 15, 2005

Key facts

Drug name ALIMTA
Document type Other Important Information from FDA
Application NDA021677
Submission ORIG-1
Company LILLY
Document date Apr 15, 2005
FDA document web.archive.org

At a glance

  • 10–99 Documents for this application
  • None USP chapters cited in this application's documents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA documents

Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date:

Browse all Drugs@FDA documents